Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 has replaced v3.4.1 on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor page/version change that does not modify the study content.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded Show glossary and Hide glossary options, and updated labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page shows a minor site revision update: an addition of Revision: v3.3.4 and removal of Revision: v3.3.3; these changes do not affect the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedExpanded and updated the Locations section with entries across multiple regions (US states, Alberta, Ontario, Gyeong Gi-do) and added Revision: v3.3.3. Older location blocks were removed.SummaryDifference1%

- Check91 days agoChange DetectedPubMed-based publication notes were updated to state that publications are automatically filled from PubMed and to include a new revision label (v3.3.2). The earlier PubMed note and revision label (v3.2.0) were removed.SummaryDifference0.1%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.